Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Merck & Co., Inc.MRK · Entity 2807 | SVP Chief Ethics & Com Officer | February 26, 2021 | March 02, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Merck & Co., Inc.
Report date February 26, 2021 · Filed March 02, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,283.334 |
Reported balance
After 2021-02-26 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-02-26 · Grant · Acquired 3,437 · Balance 10,283.334 F1: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/18. Performance shares were paid out at 166 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2020. F2: Holdings include shares acquired in dividend reinvestment transactions. |
Filing footnotes · ownership attribution and instrument terms
F1: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/18. Performance shares were paid out at 166 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2020.
F2: Holdings include shares acquired in dividend reinvestment transactions.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2021 Filed Mar 2, 2021 16:35 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantCommon Stock | 3,437 | $72.62 | $249,594.94 |
DisclosureSEC source: 0001127602-21-008565 · form4.xml · nonDerivative · entry 1 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,283.334 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/18. Performance shares were paid out at 166 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2020. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 05, 2020 Filed May 6, 2020 21:16 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionRestricted Stock Unit · Derivative | 1,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015657 · form4.xml · derivative · entry 6 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,290 shares Expires 2020-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 05, 2020 Filed May 6, 2020 21:16 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 458 | $76.86 | $35,201.88 |
DisclosureSEC source: 0001127602-20-015657 · form4.xml · nonDerivative · entry 4 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,846.334 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 05, 2020 Filed May 6, 2020 21:16 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 1,290 | $76.86 | $99,149.40 |
DisclosureSEC source: 0001127602-20-015657 · form4.xml · nonDerivative · entry 3 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,304.334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2020 Filed May 6, 2020 21:16 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionRestricted Stock Unit · Derivative | 692 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015657 · form4.xml · derivative · entry 5 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 694 Underlying: Common Stock · 692 shares Expires 2021-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F3 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021. Read SEC document |
| May 04, 2020 Filed May 6, 2020 21:16 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 238 | $77.67 | $18,485.46 |
DisclosureSEC source: 0001127602-20-015657 · form4.xml · nonDerivative · entry 2 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,014.334 Read SEC document |
| May 04, 2020 Filed May 6, 2020 21:16 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 692 | $77.67 | $53,747.64 |
DisclosureSEC source: 0001127602-20-015657 · form4.xml · nonDerivative · entry 1 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,252.334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2020 Filed May 5, 2020 20:42 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionRestricted Stock Unit · Derivative | 1,541 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015447 · form4.xml · derivative · entry 5 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,084 Underlying: Common Stock · 1,541 shares Expires 2022-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F5 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022. Read SEC document |
| May 03, 2020 Filed May 5, 2020 20:42 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 529 | $77.67 | $41,087.43 |
DisclosureSEC source: 0001127602-20-015447 · form4.xml · nonDerivative · entry 2 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,560.334 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 03, 2020 Filed May 5, 2020 20:42 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 1,541 | $77.67 | $119,689.47 |
DisclosureSEC source: 0001127602-20-015447 · form4.xml · nonDerivative · entry 1 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,089.334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:42 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantRestricted Stock Unit · Derivative | 2,704 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015447 · form4.xml · derivative · entry 4 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,704 Underlying: Common Stock · 2,704 shares Expires 2023-05-01 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F4 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:42 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (Right to Buy) · Derivative | 21,144 | $0.00 Strike: $77.67 | $0.00 |
DisclosureSEC source: 0001127602-20-015447 · form4.xml · derivative · entry 3 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,144 Underlying: Common Stock · 21,144 shares Expires 2030-04-30 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:27 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantCommon Stock | 1,659 | $76.56 | $127,013.04 |
DisclosureSEC source: 0001127602-20-009142 · form4.xml · nonDerivative · entry 1 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,513.879 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/17. Performance shares were paid out at 137 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2019. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 10, 2019 Filed May 13, 2019 21:05 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionRestricted Stock Unit · Derivative | 1,509 | $78.33 | $118,199.97 |
DisclosureSEC source: 0001104659-19-028976 · a4.xml · derivative · entry 3 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,509 shares Expires 2019-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 10, 2019 Filed May 13, 2019 21:05 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 517 | $78.33 | $40,496.61 |
DisclosureSEC source: 0001104659-19-028976 · a4.xml · nonDerivative · entry 2 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,799.829 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 10, 2019 Filed May 13, 2019 21:05 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 1,509 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-028976 · a4.xml · nonDerivative · entry 1 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,316.829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2019 Filed May 8, 2019 00:32 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionRestricted Stock Unit · Derivative | 692 | $80.00 | $55,360.00 |
DisclosureSEC source: 0001104659-19-027601 · a4.xml · derivative · entry 4 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,386 Underlying: Common Stock · 692 shares Expires 2021-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F4 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021. Read SEC document |
| May 04, 2019 Filed May 8, 2019 00:32 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 238 | $80.00 | $19,040.00 |
DisclosureSEC source: 0001104659-19-027601 · a4.xml · nonDerivative · entry 2 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,807.829 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 04, 2019 Filed May 8, 2019 00:32 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 692 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-027601 · a4.xml · nonDerivative · entry 1 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,045.829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2019 Filed May 8, 2019 00:32 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantRestricted Stock Unit · Derivative | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-027601 · a4.xml · derivative · entry 5 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires 2022-05-03 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F5 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022. Read SEC document |
| May 03, 2019 Filed May 8, 2019 00:32 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 11,291 | $0.00 Strike: $80.00 | $0.00 |
DisclosureSEC source: 0001104659-19-027601 · a4.xml · derivative · entry 3 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,291 Underlying: Common Stock · 11,291 shares Expires 2029-05-02 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022. Read SEC document |
| May 03, 2019 Filed Dec 16, 2019 16:17 UTC Amendment | Merck & Co., Inc. MRK · Entity 2807 | GrantRestricted Stock Unit · Derivative | 4,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-034976 · form4a.xml · derivative · entry 1 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,625 Underlying: Common Stock · 4,625 shares Expires 2022-05-03 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F2 · shares: The original Form 4, filed on May 7, 2019, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the number of restricted stock units granted on May 3, 2019. As a result of this administrative error, the number of restricted stock units granted to the reporting person following the corrected transaction reflects an increase by 3,125 shares in the number of restricted stock units reported. F3 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022. F2 · derivative.underlying_shares: The original Form 4, filed on May 7, 2019, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the number of restricted stock units granted on May 3, 2019. As a result of this administrative error, the number of restricted stock units granted to the reporting person following the corrected transaction reflects an increase by 3,125 shares in the number of restricted stock units reported. F2 · balance_after: The original Form 4, filed on May 7, 2019, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the number of restricted stock units granted on May 3, 2019. As a result of this administrative error, the number of restricted stock units granted to the reporting person following the corrected transaction reflects an increase by 3,125 shares in the number of restricted stock units reported. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.